Citations

Showing 10 of 108083 citations.

“Pinball” intrusions in spinocerebellar ataxia type 3
Lemos, João , Novo, Ana Margarida , Duque, Cristina , Castelhano, João , Eggenberger, Eric , Januário, Cristina , Novo, Ana, Lemos, João , Januário, Cristina

Mayo Clinic

Neurology | November 29, 2017 | Volume: 90 | Issue: 1 | Pages: 36-37

10.1212/wnl.0000000000004772 | PMID 29187517 Get It

Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma
Ferrufino‐Schmidt, María C. , Medeiros, L. Jeffrey , Liu, Hui , Clemens, Mark W. , Laurent, Camille , Lofts, Julian , Amin, Mitual , Chai, Siaw Ming , Morine, Angela, Napoli, Arianna Di , Bhagat, Govind , Tritz, Denise, Quesada, Andres , Hu, Qinlong, Gómez, Francisco Javier García , Martín, Juan José Borrero , Thakral, Beenu , Narbaitz, Marina, Hughes, R. Condon, Yang, Li-Jun, Fromm, Jonathan R. , Wu, David , Sohani, Aliyah R. , Vadlamani, Indira U., Ferry, Judith A. , Szigeti, Réka , Tardío, Juan C. , Granados, Rosario , Dertinger, Susanne, Offner, Felix, Pircher, Andreas , Hosry, Jeff , Miranda, Roberto N. , Horna, Pedro , Di Napoli, Arianna , Hunt, Kelly K. , Doǧan, Ahmet , Parkash, Vinita , Piña‐Oviedo, Sergio , Zhang, Da , Hunt, John, Vadlamani, Indira, Morgan, Elizabeth A. , Young, Ken H. , Medeiros, L Jeffrey , Bhagat, Govind , Miranda, Roberto N

Mayo Clinic

American Journal of Surgical Pathology | November 29, 2017 | Volume: 42 | Issue: 3 | Pages: 293-305

10.1097/pas.0000000000000985 | PMID 29194092 Get It

Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a rare T-cell lymphoma that arises around breast implants. Most patients manifest with periprosthetic effusion, whereas a subset of patients develops a tumor mass or lymph node involvement (LNI). The aim of this study is to describe the pathologic features of lymph nodes from patients with BI-ALCL and assess the prognostic impact of LNI. Clinical findings and histopathologic features of lymph nodes were assessed in 70 patients with BI-ALCL. LNI was defined by the histologic demonstration of ALCL in lymph nodes. Fourteen (20%) patients with BI-ALCL had LNI, all lymph nodes involved were regional, the most frequent were axillary (93%). The pattern of involvement was sinusoidal in 13 (92.9%) cases, often associated with perifollicular, interfollicular, and diffuse patterns. Two cases had Hodgkin-like patterns. The 5-year overall survival was 75% for patients with LNI and 97.9% for patients without LNI at presentation (P=0.003). Six of 49 (12.2%) of patients with tumor confined by the capsule had LNI, compared with LNI in 8/21 (38%) patients with tumor beyond the capsule. Most patients with LNI achieved complete remission after various therapeutic approaches. Two of 14 (14.3%) patients with LNI died of disease compared with 0/56 (0%) patients without LNI. Twenty percent of patients with BI-ALCL had LNI by lymphoma, most often in a sinusoidal pattern. We conclude that BI-ALCL beyond capsule is associated with a higher risk of LNI. Involvement of lymph nodes was associated with decreased overall survival. Misdiagnosis as Hodgkin lymphoma is a pitfall.
CRRL269: a novel designer and renal-enhancing pGC-A peptide activator
Chen, Yang, Harty, Gail J., Huntley, Brenda K., Heublein, Denise M., Harders, Gerald E., Meems, Laura M.G., Pan, Shuchong, Sangaralingham, S. Jeson , Ichiki, Tomoko , Burnett, John C. , Iyer, Seethalakshmi R., Meems, Laura, Chen, Yang, Iyer, Seethalakshmi , Sangaralingham, S. Jeson

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | November 29, 2017 | Volume: 314 | Issue: 3 | Pages: R407-R414

10.1152/ajpregu.00286.2017 | PMID 29187381 Get It

The natriuretic peptides (NPs) B-type NP (BNP) and urodilatin (URO) exert renal protective properties via the particulate guanylyl cyclase A receptor (pGC-A). As a potential renal-enhancing strategy, we engineered a novel designer peptide that we call CRRL269. CRRL269 was investigated in human cell lines and in normal canines to define potential cardiorenal enhancing actions. The mechanism of its cardiorenal selective properties was also investigated. In vitro NP receptor activity was quantified with guanosine 3′,5′-cyclic monophosphate generation. In vivo effects were determined in normal canine acute infusion studies. We observed that CRRL269 demonstrated enhanced pGC-A activity in renal compared with nonrenal cell lines. CRRL269 exerted enhanced resistance to neprilysin compared with URO. Importantly, CRRL269 exhibited significant and greater increases in urinary sodium excretion and diuresis, with less blood pressure reduction, than BNP or URO in normal canines. CRRL269 retained potent renin-angiotensin-aldosterone system (RAAS) suppressing properties shared by URO and BNP. Also, CRRL269 exerted less arterial relaxation and higher cAMP cardiomyocytes generation than BNP. CRRL269 possessed superior renal and pGC-A activating properties compared with BNP or URO in vitro. CRRL269 exerted enhanced renal actions while suppressing RAAS in vivo and with less hypotension compared with URO or BNP. Together, our study suggests that CRRL269 is a promising innovative renal-enhancing drug, with favorable protective actions targeting cardiorenal disease states through the pGC-A receptor.
Rhabdomyolysis and fluctuating asymptomatic hyperCKemia associated with CACNA1S variant
Anandan, Charenya, Cipriani, Marina, Laughlin, Ruple S. , Milone, Margherita , Milone, M , Niu, Zhiyv

Mayo Clinic

European Journal of Neurology | November 29, 2017 | Volume: 25 | Issue: 2 | Pages: 417-419

10.1111/ene.13528 | PMID 29193480 Get It

Background and purposeCACNA1S encodes Cav1.1, a voltage sensor for muscle excitation−contraction coupling, which activates the ryanodine receptor 1 (RYR1) leading to calcium release from the sarcoplasmic reticulum. CACNA1S mutations cause hypokalemic periodic paralysis, malignant hyperthermia and congenital myopathy. RYR1 mutations result in congenital myopathy, malignant hyperthermia and rhabdomyolysis.MethodsThe aim was to describe a novel phenotype associated with a CACNA1S variant at a site previously linked to hypokalemic periodic paralysis.ResultsThe patient presented with fluctuating asymptomatic creatine kinase elevation after an episode of rhabdomyolysis but has no history of periodic paralysis. His muscle biopsy showed core‐like structures occurring mainly in type 2 fibers. He carries a novel Cav1.1 variant (p.Arg528Leu) affecting a highly conserved amino acid. Different mutations at the same location cause hypokalemic periodic paralysis.ConclusionThis case underscores the similarity between the phenotypes caused by mutations in two functionally linked proteins, RYR1 and Cav1.1.
A path to understanding autoimmune GFAP astrocytopathy
Ζεκερίδου, Αναστασία , McKeon, Andrew , Flanagan, E P , McKeon, Andrew , Flanagan, Eoin P.

Mayo Clinic

European Journal of Neurology | November 29, 2017 | Volume: 25 | Issue: 3 | Pages: 421-422

10.1111/ene.13527 | PMID 29193488 Get It

Click here to view the accompanying paper in this volume.
Online education improves pediatric residents’ understanding of atopic dermatitis
Craddock, Megan , Blondin, Heather M., Youssef, Molly J. , Tollefson, Megha M. , Hill, Lauren , Hanson, Janice L. , Bruckner, Anna L. , Craddock, Megan F

Mayo Clinic

Pediatric Dermatology | November 29, 2017 | Volume: 35 | Issue: 1 | Pages: 64-69

10.1111/pde.13323 | PMID 29193379 Get It

AbstractBackground/ObjectivesPediatricians manage skin conditions such as atopic dermatitis (AD) but report that their dermatologic training is inadequate. Online modules may enhance medical education when sufficient didactic or clinical teaching experiences are lacking. We assessed whether an online module about AD improved pediatric residents’ knowledge and changed their clinical management of AD.MethodsTarget and control cohorts of pediatric residents from two institutions were recruited. Target subjects took a 30‐question test about AD early in their residency, reviewed the online module, and repeated the test 6 months and 1 year later. The control subjects, who had 1 year of clinical experience but had not reviewed the online module, also took the test. The mean percentage of correct answers was calculated and compared using two‐sided, two‐sample independent t tests and repeated‐measures analysis of variance. For a subset of participants, clinical documentation from AD encounters was reviewed and 13 practice behaviors were compared using the Fisher exact test.ResultsTwenty‐five subjects in the target cohort and 29 subjects in the control cohort completed the study. The target cohort improved from 18.0 ± 3.2 to 23.4 ± 3.4 correctly answered questions over 1 year (P < .001). This final value was greater than that of the control cohort (20.7 ± 4.5; P = .01). Meaningful differences in practice behaviors were not seen.ConclusionPediatric residents who reviewed an online module about AD demonstrated statistically significant improvement in disease‐specific knowledge over time and had statistically significantly higher scores than controls. Online dermatology education may effectively supplement traditional clinical teaching.
A rapid T1 mapping method for assessment of murine kidney viability using dynamic manganese‐enhanced magnetic resonance imaging
Jiang, Kai , Mishra, Prasanna K. , Lerman, Lilach O. , Macura, Slobodan I, Tang, Hui Jun , Macura, Slobodan

Mayo Clinic

Magnetic Resonance in Medicine | November 29, 2017 | Volume: 80 | Issue: 1 | Pages: 190-199

10.1002/mrm.27025 | PMID 29193339 Get It

PurposeDynamic manganese‐enhanced MRI (MEMRI) allows assessment of tissue viability by tracing manganese uptake. We aimed to develop a rapid T1 mapping method for dynamic MEMRI to facilitate assessments of murine kidney viability.MethodsA multi‐slice saturation recovery fast spin echo (MSRFSE) was developed, validated, and subsequently applied in dynamic MEMRI at 16.4T on ischemic mouse kidneys after 4 weeks of unilateral renal artery stenosis (RAS). Baseline T1 values and post‐contrast R1 (1/T1) changes were measured in cortex (CO), outer (OSOM), inner (ISOM) strips of outer medulla, and inner medulla (IM).ResultsValidation studies showed strong agreement between MSRFSE and an established saturation recovery Look‐Locker method. Baseline T1 (s) increased in the stenotic kidney CO (2.10 [1.95–2.56] vs. 1.88 [1.81–2.00], P = 0.0317) and OSOM (2.17 [2.05–2.33] vs. 1.96 [1.87–2.00], P = 0.0075) but remained unchanged in ISOM and IM. This method allowed a temporal resolution of 1.43 min in dynamic MEMRI. Mn2+ uptake and retention decreased in stenotic kidneys, particularly in the OSOM (ΔR1: 0.48 [0.38–0.56] vs. 0.64 [0.61–0.69] s−1, P < 0.0001).ConclusionDynamic MEMRI by MSRFSE detected decreased cellular viability and discerned the regional responses to RAS. This technique may provide a valuable tool for noninvasive evaluation of renal viability. Magn Reson Med 80:190–199, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Artificial neural networks for stiffness estimation in magnetic resonance elastography
Murphy, Matthew C. , Trzasko, Joshua D. , Glaser, Kevin J. , Manduca, Armando , Huston, John , Ehman, Richard L.

Mayo Clinic

Magnetic Resonance in Medicine | November 29, 2017 | Volume: 80 | Issue: 1 | Pages: 351-360

10.1002/mrm.27019 | PMID 29193306 Get It

PurposeTo investigate the feasibility of using artificial neural networks to estimate stiffness from MR elastography (MRE) data.MethodsArtificial neural networks were fit using model‐based training patterns to estimate stiffness from images of displacement using a patch size of ∼1 cm in each dimension. These neural network inversions (NNIs) were then evaluated in a set of simulation experiments designed to investigate the effects of wave interference and noise on NNI accuracy. NNI was also tested in vivo, comparing NNI results against currently used methods.ResultsIn 4 simulation experiments, NNI performed as well or better than direct inversion (DI) for predicting the known stiffness of the data. Summary NNI results were also shown to be significantly correlated with DI results in the liver (R2 = 0.974) and in the brain (R2 = 0.915), and also correlated with established biological effects including fibrosis stage in the liver and age in the brain. Finally, repeatability error was lower in the brain using NNI compared to DI, and voxel‐wise modeling using NNI stiffness maps detected larger effects than using DI maps with similar levels of smoothing.ConclusionArtificial neural networks represent a new approach to inversion of MRE data. Summary results from NNI and DI are highly correlated and both are capable of detecting biologically relevant signals. Preliminary evidence suggests that NNI stiffness estimates may be more resistant to noise than an algebraic DI approach. Taken together, these results merit future investigation into NNIs to improve the estimation of stiffness in small regions. Magn Reson Med 80:351–360, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Clinical and genetic characterization of AP4B1‐associated SPG47
Ebrahimi‐Fakhari, Darius , Cheng, Chi Vicky , Dies, Kira A. , Diplock, Amelia, Pier, Danielle B. , Ryan, Conor S. , Lanpher, Brendan C. , Hirst, Jennifer , Şahin, Mustafa , Rosser, Elisabeth, Darras, Basil T. , CureSPG47, on behalf of, Bennett, James T , Chung, Wendy K. , CureSPG47, on behalf of, Pier, Danielle , Ebrahimi-Fakhari, Darius

Mayo Clinic

American Journal of Medical Genetics Part A | November 29, 2017 | Volume: 176 | Issue: 2 | Pages: 311-318

10.1002/ajmg.a.38561 | PMID 29193663 Get It

The hereditary spastic paraplegias (HSPs) are a heterogeneous group of disorders characterized by degeneration of the corticospinal and spinocerebellar tracts leading to progressive spasticity. One subtype, spastic paraplegia type 47 (SPG47 or HSP‐AP4B1), is due to bi‐allelic loss‐of‐function mutations in the AP4B1 gene. AP4B1 is a subunit of the adapter protein complex 4 (AP‐4), a heterotetrameric protein complex that regulates the transport of membrane proteins. Since 2011, 11 individuals from six families with AP4B1 mutations have been reported, nine of whom had homozygous mutations and were from consanguineous families. Here we report eight patients with AP4B1‐associated SPG47, the majority born to non‐consanguineous parents and carrying compound heterozygous mutations. Core clinical features in this cohort and previously published patients include neonatal hypotonia that progresses to spasticity, early onset developmental delay with prominent motor delay and severely impaired or absent speech development, episodes of stereotypic laughter, seizures including frequent febrile seizures, thinning of the corpus callosum, and delayed myelination/white matter loss. Given that some of the features of AP‐4 deficiency overlap with those of cerebral palsy, and the discovery of the disorder in non‐consanguineous populations, we believe that AP‐4 deficiency may be more common than previously appreciated.